
    
      This is a prospective safety surveillance study in a US military Department of Defense (DoD)
      population. Military subjects either naive to smallpox immunization and have received
      ACAM2000® vaccine or who have previously been immunized with a vaccinia vaccine, usually
      Dryvax®, will be enrolled into the study.

      No vaccine will be administered as part of this study.
    
  